Literature DB >> 11985786

Reversibility of heterotopic proliferative glands in glandular stomach of Helicobacter pylori-infected Mongolian gerbils on eradication.

Koji Nozaki1, Nobuyuki Shimizu, Tetsuya Tsukamoto, Ken-Ichi Inada, Xueyuan Cao, Yuzuru Ikehara, Michio Kaminishi, Atsushi Sugiyama, Masae Tatematsu.   

Abstract

Helicobacter pylori (Hp) infection is an important factor in human gastric disorders. Mongolian gerbils can be easily infected with Hp and represent excellent experimental models to clarify the role of Hp in chronic active gastritis, peptic ulcers, intestinal metaplasia, and gastric carcinoma. We have proved the enhancing effects of Hp infection on all histological types of gastric cancers in Mongolian gerbils exposed to chemical carcinogens. Heterotopic proliferative glands (HPGs) also frequently develop with Hp infection in the glandular stomach of infected gerbils, with a slightly dysplastic change of constituent cells. Distinguishing reversible inflammatory lesions from true neoplasms upon eradication is necessary for further biological or histochemical investigations using this model. We employed an experimental model of long-term Hp infection and eradication in gerbils. HPGs finally developed with a phenotypic shift of intestinalization with Paneth cells. After eradication, HPGs were obviously reduced, and gastric lesions in mucosa also improved with few remnants of the former injury. This shows that reversible HPGs are frequently induced solely by Hp infection in this animal species, and are related to severe gastritis, rather than being malignant in character. Thus, distinguishing reversible lesions from true neoplasms is necessary to investigate the relationship of Hp infection and gastric carcinogenesis in this animal model.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11985786      PMCID: PMC5927020          DOI: 10.1111/j.1349-7006.2002.tb01267.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  18 in total

1.  Helicobacter pylori infection enhances glandular stomach carcinogenesis in Mongolian gerbils treated with chemical carcinogens.

Authors:  N Shimizu; K Inada; H Nakanishi; T Tsukamoto; Y Ikehara; M Kaminishi; S Kuramoto; A Sugiyama; T Katsuyama; M Tatematsu
Journal:  Carcinogenesis       Date:  1999-04       Impact factor: 4.944

2.  The complete genome sequence of the gastric pathogen Helicobacter pylori.

Authors:  J F Tomb; O White; A R Kerlavage; R A Clayton; G G Sutton; R D Fleischmann; K A Ketchum; H P Klenk; S Gill; B A Dougherty; K Nelson; J Quackenbush; L Zhou; E F Kirkness; S Peterson; B Loftus; D Richardson; R Dodson; H G Khalak; A Glodek; K McKenney; L M Fitzegerald; N Lee; M D Adams; E K Hickey; D E Berg; J D Gocayne; T R Utterback; J D Peterson; J M Kelley; M D Cotton; J M Weidman; C Fujii; C Bowman; L Watthey; E Wallin; W S Hayes; M Borodovsky; P D Karp; H O Smith; C M Fraser; J C Venter
Journal:  Nature       Date:  1997-08-07       Impact factor: 49.962

3.  Development of poorly differentiated adenocarcinoma and carcinoid due to long-term Helicobacter pylori colonization in Mongolian gerbils.

Authors:  F Hirayama; S Takagi; E Iwao; Y Yokoyama; K Haga; S Hanada
Journal:  J Gastroenterol       Date:  1999-08       Impact factor: 7.527

4.  New animal model of glandular stomach carcinogenesis in Mongolian gerbils infected with Helicobacter pylori and treated with a chemical carcinogen.

Authors:  N Shimizu; K I Inada; T Tsukamoto; H Nakanishi; Y Ikehara; A Yoshikawa; M Kaminishi; S Kuramoto; M Tatematsu
Journal:  J Gastroenterol       Date:  1999       Impact factor: 7.527

5.  Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation.

Authors:  D Forman; D G Newell; F Fullerton; J W Yarnell; A R Stacey; N Wald; F Sitas
Journal:  BMJ       Date:  1991-06-01

6.  An apparent lack of association between Helicobacter pylori infection and risk of gastric cancer in China.

Authors:  P M Webb; M C Yu; D Forman; B E Henderson; D G Newell; J M Yuan; Y T Gao; R K Ross
Journal:  Int J Cancer       Date:  1996-09-04       Impact factor: 7.396

7.  Helicobacter pylori infection induces gastric cancer in mongolian gerbils.

Authors:  T Watanabe; M Tada; H Nagai; S Sasaki; M Nakao
Journal:  Gastroenterology       Date:  1998-09       Impact factor: 22.682

8.  Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii.

Authors:  A Nomura; G N Stemmermann; P H Chyou; I Kato; G I Perez-Perez; M J Blaser
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

9.  Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori.

Authors:  R A Alm; L S Ling; D T Moir; B L King; E D Brown; P C Doig; D R Smith; B Noonan; B C Guild; B L deJonge; G Carmel; P J Tummino; A Caruso; M Uria-Nickelsen; D M Mills; C Ives; R Gibson; D Merberg; S D Mills; Q Jiang; D E Taylor; G F Vovis; T J Trust
Journal:  Nature       Date:  1999-01-14       Impact factor: 49.962

10.  Induction of glandular stomach cancers in Helicobacter pylori-sensitive Mongolian gerbils treated with N-methyl-N-nitrosourea and N-methyl-N'-nitro-N-nitrosoguanidine in drinking water.

Authors:  M Tatematsu; M Yamamoto; N Shimizu; A Yoshikawa; H Fukami; M Kaminishi; T Oohara; A Sugiyama; T Ikeno
Journal:  Jpn J Cancer Res       Date:  1998-02
View more
  14 in total

1.  The Mongolian Gerbil: A Robust Model of Helicobacter pylori-Induced Gastric Inflammation and Cancer.

Authors:  Jennifer M Noto; Judith Romero-Gallo; M Blanca Piazuelo; Richard M Peek
Journal:  Methods Mol Biol       Date:  2016

2.  Expression of small intestinal and colonic phenotypes in complete intestinal metaplasia of the human stomach.

Authors:  Harunari Tanaka; Tetsuya Tsukamoto; Tsutomu Mizoshita; Ken-ichi Inada; Naotaka Ogasawara; Xueyuan Cao; Sosuke Kato; Takashi Joh; Masae Tatematsu
Journal:  Virchows Arch       Date:  2005-08-09       Impact factor: 4.064

3.  Role of Helicobacter pylori in Gastric Neoplasia.

Authors:  Tetsuya Tsukamoto; Masae Tatematsu
Journal:  Curr Infect Dis Rep       Date:  2014-05       Impact factor: 3.725

Review 4.  Gastric-and-intestinal mixed-type intestinal metaplasia: aberrant expression of transcription factors and stem cell intestinalization.

Authors:  Tetsuya Tsukamoto; Tsutomu Mizoshita; Masae Tatematsu
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

Review 5.  Effects of eradication of Helicobacter pylori on gastric carcinogenesis in experimental models.

Authors:  Masae Tatematsu; Tetsuya Tsukamoto; Takeshi Toyoda
Journal:  J Gastroenterol       Date:  2007-01       Impact factor: 7.527

Review 6.  Gastric cancer: animal studies on the risk of hypoacidity and hypergastrinemia.

Authors:  Reidar Fossmark; Gunnar Qvigstad; Helge-L Waldum
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

7.  Characterization of progressive metaplasia in the gastric corpus mucosa of Mongolian gerbils infected with Helicobacter pylori.

Authors:  Takahiro Shimizu; Eunyoung Choi; Christine P Petersen; Jennifer M Noto; Judith Romero-Gallo; Maria B Piazuelo; M Kay Washington; Richard M Peek; James R Goldenring
Journal:  J Pathol       Date:  2016-06-22       Impact factor: 7.996

Review 8.  Helicobacter pylori infection and gastric carcinogenesis in rodent models.

Authors:  Tetsuya Tsukamoto; Takeshi Toyoda; Tsutomu Mizoshita; Masae Tatematsu
Journal:  Semin Immunopathol       Date:  2012-10-31       Impact factor: 9.623

9.  Intestinal metaplasia -the effect of Acid on the gastric mucosa and gastric carcinogenesis-.

Authors:  Hiromitsu Watanabe
Journal:  J Toxicol Pathol       Date:  2010-10-05       Impact factor: 1.628

10.  Salt and stress synergize H. pylori-induced gastric lesions, cell proliferation, and p21 expression in Mongolian gerbils.

Authors:  Armando Gamboa-Dominguez; Tom Ubbelohde; Milena Saqui-Salces; Luis Romano-Mazzoti; Minerva Cervantes; Claudia Domínguez-Fonseca; Maria de la Luz Estreber; Guillermo M Ruíz-Palacios
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.